World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
8738
World Ranking
4519
National Ranking
2042

Brian R. Curtis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Brian R. Curtis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 176 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Brian R. Curtis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Brian R. Curtis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Brian R. Curtis is affiliated with the University of Wisconsin-Milwaukee in the United States. Their research primarily focuses on the field of Medicine, with a particular emphasis on Hematology, Surgery, Genetics, Immunology, and Internal Medicine as subfields of study.

The scientist's work covers several main topics including Platelet Disorders and Treatments, Blood groups and transfusion, Heparin-Induced Thrombocytopenia and Thrombosis, Blood disorders and treatments, Venous Thromboembolism Diagnosis and Management, Immunodeficiency and Autoimmune Disorders, and Erythrocyte Function and Pathophysiology.

The recent publications by Brian R. Curtis include the following papers:

  • "A prospective, blinded study of a PF4-dependent assay for HIT diagnosis" (2020) published in Blood
  • "Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia" (2020) published in Nucleic Acid Therapeutics
  • "Successful treatment of thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26.COV2.S vaccination" (2021) published in American Journal of Hematology
  • "Generation of 'designer erythroblasts' lacking one or more blood group systems from CRISPR/Cas9 gene-edited human-induced pluripotent stem cells" (2021) published in Journal of Cellular and Molecular Medicine
  • "Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology" (2021) published in Journal of Thrombosis and Haemostasis

Frequent co-authors collaborating with Brian R. Curtis include:

  • Nanyan Zhang
  • Peter J. Newman
  • Gregory A. Denomme
  • Mia J. Sullivan
  • Ruchika Sharma

The scientist has published multiple articles in several journals, with the most frequent publication venues listed as:

  • Transfusion
  • Blood
  • Nucleic Acid Therapeutics
  • American Journal of Hematology
  • Journal of Cellular and Molecular Medicine

Best Publications

  • Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype

    Eugene A Podrez;Tatiana V Byzova;Maria Febbraio;Robert G Salomon

  • Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management

    Richard H Aster;Brian R Curtis;Janice G McFarland;Daniel W Bougie

  • Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice.

    Grace M. Thomas;Grace M. Thomas;Carla Carbo;Carla Carbo;Brian R. Curtis;Kimberly Martinod;Kimberly Martinod

  • Malaria susceptibility and CD36 mutation.

    Timothy J. Aitman;Lisa D. Cooper;Penny J. Norsworthy;Faisal N. Wahid

  • Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia

    Anne Davoren;Brian R. Curtis;Richard H. Aster;Jarice G. McFarland

  • Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.

    Daniel W. Bougie;Peter R. Wilker;Elizabeth D. Wuitschick;Brian R. Curtis

  • Vancomycin-induced immune thrombocytopenia.

    Annette Von Drygalski;Brian R. Curtis;Daniel W. Bougie;Janice G. McFarland

  • TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities

    A. Davoren;B.R. Curtis;I.A. Shulman;A.F. Mohrbacher

  • Anti-GPVI–associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface

    Brian Boylan;Hong Chen;Vipul Rathore;Cathy Paddock

  • Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management

    Julie A. Peterson;Janice G. McFarland;Brian R. Curtis;Richard H. Aster

  • Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods

    Jessica A. Reese;Xiaoning Li;Manfred Hauben;Richard H. Aster;Richard H. Aster

  • Human platelet antigens - 2013.

    B. R. Curtis;J. G. McFarland

  • Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model

    Christopher C. Silliman;Brian R. Curtis;Patricia M. Kopko;Samina Y. Khan

  • Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets

    Brian R. Curtis;Julia Swyers;Ajit Divgi;Janice G. McFarland

  • Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex

    Brian R. Curtis;Janice G. McFarland;Guo-Guang Wu;Gian P. Visentin

  • Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin

    Brian R. Curtis;James Kaliszewski;Marisa B. Marques;M. Wasif Saif

  • Mechanisms of transfusion-related acute lung injury (TRALI): Anti-leukocyte antibodies

    Brian R. Curtis;Janice G. McFarland

  • IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia

    Anand Padmanabhan;Curtis G. Jones;Shannon M. Pechauer;Brian R. Curtis

  • Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin

    Jessica A. Reese;Daniel W. Bougie;Brian R. Curtis;Deirdra R Terrell

  • Blood group A and B antigens are strongly expressed on platelets of some individuals.

    Brian R. Curtis;Jennifer T. Edwards;Martin J. Hessner;John P. Klein

Frequent Co-Authors

Richard H. Aster
Richard H. Aster Medical College of Wisconsin
Janice G. McFarland
Janice G. McFarland Medical College of Wisconsin
Demin Wang
Demin Wang Medical College of Wisconsin
Peter J. Newman
Peter J. Newman Medical College of Wisconsin
James N. George
James N. George University of Oklahoma Health Sciences Center
James B. Bussel
James B. Bussel Cornell University
Martin J. Hessner
Martin J. Hessner Medical College of Wisconsin
Christopher C. Silliman
Christopher C. Silliman University of Colorado Denver
John H. Hartwig
John H. Hartwig Brigham and Women's Hospital
Ulrich H. von Andrian
Ulrich H. von Andrian Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related online degrees in nursing can open diverse career pathways in healthcare. Many accelerated programs allow students to fast-track their education and enter the workforce sooner. For example, accelerated FNP programs enable nurses to become Family Nurse Practitioners through focused, intensive study.

Non-nursing students looking to enter this field might explore 12-month accelerated nursing programs online for non nurses, which provide a streamlined route to nursing licensure. These programs are designed to build foundational knowledge quickly, ideal for career changers.

When time and admission flexibility are key, options such as easiest accelerated nursing programs to get into offer accessible entry points for students aiming to advance their credentials without lengthy prerequisites. Similarly, fastest and easiest LPN programs can serve as a practical starting point, allowing learners to begin clinical work in a shorter timeframe.

Exploring these educational pathways helps aspiring healthcare professionals align their immunology interests with well-established nursing roles, enhancing their scope of practice and job market competitiveness.

Best Scientists Citing Brian R. Curtis

Trending Scientists